← Back to headlines
Harvard Bioscience Reports Q4 GAAP EPS and Revenue
Harvard Bioscience announced a GAAP EPS of -$0.06 and revenue of $23.7 million for the fourth quarter.
12 Mar, 11:38 — 12 Mar, 11:38
Sources
Showing 1 of 1 sources
Harvard Bioscience announced a GAAP EPS of -$0.06 and revenue of $23.7 million for the fourth quarter.
